Point-Structured Human Body Modeling Based on 3D Scan Data

A novel point-structured geometrical modelling for realistic human body is introduced in this paper. This technique is based on the feature extraction from the 3D body scan data. Anatomic feature such as the neck, the arm pits, the crotch points, and other major feature points are recognized. The body data is then segmented into 6 major parts. A body model is then constructed by re-sampling the scanned data to create a point-structured mesh. The body model contains body geodetic landmarks in latitudinal and longitudinal curves passing through those feature points. The body model preserves the perfect body shape and all the body dimensions but requires little space. Therefore, the body model can be used as a mannequin in garment industry, or as a manikin in various human factor designs, but the most important application is to use as a virtue character to animate the body motion in mocap (motion capture) systems. By adding suitable joint freedoms between the segmented body links, kinematic and dynamic properties of the motion theories can be applied to the body model. As a result, a 3D virtual character that is fully resembled the original scanned individual is vividly animating the body motions. The gaps between the body segments due to motion can be filled up by skin blending technique using the characteristic of the point-structured model. The model has the potential to serve as a standardized datatype to archive body information for all custom-made products

Point-Structured Human Body Modeling Based on 3D Scan Data

A novel point-structured geometrical modelling for realistic human body is introduced in this paper. This technique is based on the feature extraction from the 3D body scan data. Anatomic feature such as the neck, the arm pits, the crotch points, and other major feature points are recognized. The body data is then segmented into 6 major parts. A body model is then constructed by re-sampling the scanned data to create a point-structured mesh. The body model contains body geodetic landmarks in latitudinal and longitudinal curves passing through those feature points. The body model preserves the perfect body shape and all the body dimensions but requires little space. Therefore, the body model can be used as a mannequin in garment industry, or as a manikin in various human factor designs, but the most important application is to use as a virtue character to animate the body motion in mocap (motion capture) systems. By adding suitable joint freedoms between the segmented body links, kinematic and dynamic properties of the motion theories can be applied to the body model. As a result, a 3D virtual character that is fully resembled the original scanned individual is vividly animating the body motions. The gaps between the body segments due to motion can be filled up by skin blending technique using the characteristic of the point-structured model. The model has the potential to serve as a standardized datatype to archive body information for all custom-made products

Apoptosis Induction in Primary Human Colorectal Cancer Cell Lines and Retarded Tumor Growth in SCID Mice by Sulforaphane

We have investigated the anticancer effects of the dietary isothiocyanate sulforaphane (SFN) on colorectal cancer (CRC), using primary cancer cells lines isolated from five Taiwanese colorectal cancer patients as the model for colorectal cancer. SFN-treated cells accumulated in metaphase (SFN 6.25 μM) and subG1 (SFN 12.5 and 25 μM) as determined by flow cytometry. In addition, treated cells showed nuclear apoptotic morphology that coincided with an activation of caspase-3, and loss of mitochondrial membrane potential (ΔΨm). Incubations at higher SFN doses (12.5 and 25 μM) resulted in cleavage of procaspase-3 and elevated caspase-2, -3, -8, and -9 activity, suggesting that the induction of apoptosis and the sulforaphane-induced mitosis delay at the lower dose are independently regulated. Daily SFN s.c. injections (400 micromol/kg/d for 3 weeks) in severe combined immunodeficient mice with primary human CRC (CP1 to CP5) s.c. tumors resulted in a decrease of mean tumor weight by 70% compared with vehicle-treated controls. Our findings suggest that, in addition to the known effects on cancer prevention, sulforaphane may have antitumor activity in established colorectal cancer

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Robust estimation of bacterial cell count from optical density

Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data

Point-Structured Human Body Modeling Based on 3D Scan Data

A novel point-structured geometrical modelling for realistic human body is introduced in this paper. This technique is based on the feature extraction from the 3D body scan data. Anatomic feature such as the neck, the arm pits, the crotch points, and other major feature points are recognized. The body data is then segmented into 6 major parts. A body model is then constructed by re-sampling the scanned data to create a point-structured mesh. The body model contains body geodetic landmarks in latitudinal and longitudinal curves passing through those feature points. The body model preserves the perfect body shape and all the body dimensions but requires little space. Therefore, the body model can be used as a mannequin in garment industry, or as a manikin in various human factor designs, but the most important application is to use as a virtue character to animate the body motion in mocap (motion capture) systems. By adding suitable joint freedoms between the segmented body links, kinematic and dynamic properties of the motion theories can be applied to the body model. As a result, a 3D virtual character that is fully resembled the original scanned individual is vividly animating the body motions. The gaps between the body segments due to motion can be filled up by skin blending technique using the characteristic of the point-structured model. The model has the potential to serve as a standardized datatype to archive body information for all custom-made products

An Embedded System for Tracking Human Motion and Humanoid Interfaces

<p><span style="font-family: Calibri, sans-serif;"><span style="font-size: 13px;">The aim of this research is using embedded CPU to develop a human motion tracking system and construct a motion replication interface for a humanoid robot. In the motion tracking system, we use a CPLD (Complex Programmable Logic Device) which is built in a central control unit (CCU) to generate synchronous signals for all the periphery devices and control the data flow from CCD boards to a PC via a USB chip. An embedded DSP on the CCD board is adopted to control the CCD exposure and conduct image processing. The peak position of exposure was computed by the on-board DSP within sub-pixel accuracy. In the construction of a motion replication interface, the same CCU is used to generate the PWM signals to drive the motors of the humanoid robot. All of the respective firmware coding methods are discussed in this article.<br /></span></span></p

Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N).

Galectins, a family of beta-galactoside-specific endogenous lectins, are involved in regulating diverse activities such as proliferation/apoptosis, cell-cell (matrix) interaction and cell migration. It is presently unclear to what extent the carbohydrate fine specificities of the combining sites of mammalian galectins overlap. To address this issue, we performed an analysis of the carbohydrate-recognition domain (CRD-I) near the N-terminus of recombinant rat galectin-4 (G4-N) by the biotin/avidin-mediated microtitre plate lectin-binding assay with natural glycoproteins (gps)/polysaccharide and by the inhibition of galectin-glycan interactions with a panel of glycosubstances. Among the 35 glycans tested for lectin binding, G4-N reacted best with human blood group ABH precursor gps, and asialo porcine salivary gps, which contain high densities of the blood group Ii determinants Galbeta1-3GalNAc (the mucin-type sugar sequence on the human erythrocyte membrane) and/or GalNAcalpha1-Ser/Thr ( Tn ), whereas this lectin domain reacted weakly or not at all with most sialylated gps. Among the oligosaccharides tested by the inhibition assay, Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc was the best. It was 666.7 and 33.3 times more potent than Gal and Galbeta1-3GlcNAc, respectively. G4-N has a preference for the beta-anomer of Gal at the non-reducing ends of oligosaccharides with a Galbeta1-3 linkage, over Galbeta1-4 and Galbeta1-6. The fraction of Tn glycopeptide from asialo ovine submandibular glycoprotein was 8.3 times more active than Galbeta1-3GlcNAc. The overall carbohydrate specificity of G4-N can be defined as Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc (lacto- N -tetraose)>Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc (lacto- N -neo-tetraose) and Tn clusters>Galbeta1-4Glc and GalNAcbeta1-3Gal>Galbeta1-3GalNAc>Galbeta1-3GlcNAc>Galbeta1-4GlcNAc>GalNAc>Gal. The definition of this binding profile provides the basis to detect differential binding properties relative to the other galectins with ensuing implications for functional analysis